Skip to content

Paion AG Sustainability Reports

PAION AG operates as a specialty pharmaceutical company focused on the development and commercialization of drugs for anesthesia and critical care. Following insolvency, its core business operations were transferred to PAION Pharma GmbH under Humanwell Healthcare.

Sector: Manufacturing

Country: Germany

Exchange: Börse Frankfurt

LEI: 529900CGHB9UWY40BU45

FIGI: BBG001S8TR26

6 reports from 2017 to 2022